Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Engineered Glove for the Objective Assessment of Hand Dexterity in Patients With Systemic Sclerosis.

ACR open rheumatology·2026
Same author

Hand bone densitometry associates with nailfold capillaroscopic severity of microvascular damage in systemic sclerosis: a pilot study.

Clinical and experimental rheumatology·2026
Same author

Fibromyalgia: the Italian survey by the ministry of health.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Frailty phenotypes and determinants of glucocorticoid-related adverse events in polymyalgia rheumatica at 12 months: a real-life single-center investigation.

Clinical rheumatology·2026
Same author

Clinical practice guidelines for reporting nail fold videocapillaroscopy: a Delphi consensus on behalf of the Italian Society of Rheumatology study group on capillaroscopy.

Clinical and experimental rheumatology·2026
Same author

Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study.

RMD open·2025
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.1K

Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment.

Maurizio Cutolo1, Stefano Soldano, Paola Contini

  • 1Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy. mcutolo@unige.it.

Clinical and Experimental Rheumatology
|December 4, 2013
PubMed
Summary
This summary is machine-generated.

CTLA4-Ig (abatacept) treatment downregulates nuclear factor-kappa B (NF-kB) expression and reduces pro-inflammatory cytokine production in human macrophages, suggesting a role in immune response modulation.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

6.8K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

7.7K

Related Experiment Videos

Last Updated: May 5, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.1K
A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

6.8K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

7.7K

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Nuclear factor-kappa B (NF-kB) is a transcription factor crucial for immune responses, regulating genes for pro-inflammatory cytokines.
  • CTLA4-Ig (abatacept) is a therapeutic agent used in immune-related conditions.

Purpose of the Study:

  • To investigate the effects of CTLA4-Ig on cytokine production and NF-kB expression in cultured human macrophages.
  • To elucidate the role of the NF-kB pathway in CTLA4-Ig-mediated macrophage responses.

Main Methods:

  • Human THP1 cells were differentiated into macrophages and treated with varying concentrations of CTLA4-Ig.
  • Quantitative RT-PCR was used to analyze mRNA expression of NF-kB, IKBα, IL-6, TNF-α, and IL-1β.
  • Western blot analysis confirmed protein expression levels of NF-kB and IKBα.

Main Results:

  • CTLA4-Ig treatment significantly downregulated NF-kB gene expression at 3 and 12 hours.
  • IKBα (NF-kB inhibitor) expression was significantly increased after 12 hours of CTLA4-Ig treatment.
  • Pro-inflammatory cytokines TNF-α, IL-6, and IL-1β showed significant downregulation following CTLA4-Ig treatment.

Conclusions:

  • The NF-kB pathway is implicated in CTLA4-Ig's modulation of macrophage cytokine expression.
  • CTLA4-Ig treatment leads to decreased NF-kB expression and increased IKBα levels in macrophages.
  • These findings suggest CTLA4-Ig influences immune responses by regulating macrophage inflammatory pathways.